Drug Profile
Research programme: tau positron emission tomography imaging agents - Alzheimer's disease - Avid Radiopharmaceuticals
Alternative Names: T 557; T 726Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Siemens Medical Solutions
- Developer Avid Radiopharmaceuticals
- Class Imaging agents; Radiopharmaceutical diagnostics; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for preclinical development in Alzheimer's-disease(Diagnosis) in USA (Parenteral, Injection)
- 18 Dec 2013 Preclinical trials in Alzheimer's disease (Diagnosis) in USA (Parenteral)